Access Whitepaper
Various types of stem cells are under investigation for therapeutic applications, and their progress towards clinical use varies. Among these, mesenchymal stem/stromal cells (MSCs) have been leading the way, outpacing other multipotent and pluripotent cell types. Given their complex in vivo microenvironment, manufacturing MSCs requires thorough consideration to maintain the relevant conditions associated with the therapeutic product.
In our new whitepaper, our Field Application Scientists:
- Share insights into the development of production processes for MSC-based therapies.
- Cover common methods for MSC isolation and considerations for MSC production.
- Explore media options, surface chemistry, and cell expansion technologies, plus considerations for cGMP manufacturing.
- Offer our learnings from working with academic and translational researchers, as well as biotech and pharmaceutical companies pushing the boundaries of MSC-based drug development, including case studies.
Thank You
Thank you for your interest in our whitepaper. A copy has also been sent out to the email address you provided on the form.